Elanco Animal Health Incorporated
ELAN
$17.80
-$0.16-0.89%
NYSE
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Net Income | 134.58% | 128.65% | 127.46% | 117.92% | -1,010.62% |
| Total Depreciation and Amortization | 1.51% | -4.01% | -5.94% | -4.95% | -3.55% |
| Total Amortization of Deferred Charges | -22.97% | -7.81% | 11.11% | 13.85% | 13.85% |
| Total Other Non-Cash Items | -157.49% | -154.53% | -154.87% | -153.67% | 1,056.70% |
| Change in Net Operating Assets | 561.11% | 334.21% | 149.67% | 145.70% | 103.27% |
| Cash from Operations | 2.69% | 27.99% | 99.63% | 310.24% | 372.03% |
| Capital Expenditure | -59.85% | -34.29% | -5.00% | 19.89% | 26.26% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -1,100.00% | -1,100.00% | -89.47% | 100.00% | 81.25% |
| Divestitures | 1,874.24% | 1,874.24% | -- | -- | -- |
| Other Investing Activities | -900.00% | -- | -90.00% | 60.00% | 112.50% |
| Cash from Investing | 1,652.24% | 1,480.52% | 785.21% | 677.62% | 68.25% |
| Total Debt Issued | 5.26% | 44.00% | -5.00% | -5.00% | 128.00% |
| Total Debt Repaid | -141.65% | -173.67% | -202.07% | -244.46% | -257.93% |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 1,775.00% | -76.92% | -183.33% | -360.00% | 15.79% |
| Cash from Financing | -254.81% | -397.54% | -1,697.59% | -5,610.71% | -940.00% |
| Foreign Exchange rate Adjustments | 48.00% | -43.33% | -658.33% | -170.00% | -257.14% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 151.02% | 425.93% | 1,557.14% | 232.97% | 135.00% |